Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.
since
auto-detected in 361 stories
3 months ago
found
a story from The Daily Mail › The Daily Mail
4 months ago
|← first ← previous page 4 of 4